{
      "brief_title": [
            "effect",
            "teriparatide",
            "postmenopausal",
            "woman",
            "osteoporosis"
      ],
      "brief_summary": [
            "effect",
            "teriparatide",
            "postmenopausal",
            "woman",
            "previously",
            "treat",
            "alendronate",
            "raloxifene"
      ],
      "condition": [
            "postmenopausal",
            "osteoporosis"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "raloxifene"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "postmenopausal",
            "woman",
            "age",
            "least",
            "50",
            "year",
            "previous",
            "clinical",
            "diagnosis",
            "osteoporosis",
            "high",
            "risk",
            "fracture",
            "current",
            "therapy",
            "least",
            "18",
            "month",
            "prior",
            "study",
            "entry",
            "either",
            "raloxifene",
            "hcl",
            "alendronate",
            "na",
            "exclusion",
            "criterion",
            "history",
            "metabolic",
            "bone",
            "disease",
            "osteoporosis",
            "history",
            "malignant",
            "neoplasm",
            "within",
            "last",
            "5",
            "year",
            "except",
            "superficial",
            "basal",
            "cell",
            "carcinoma",
            "squamous",
            "cell",
            "carcinoma"
      ],
      "gender": [
            "female"
      ],
      "minimum_age": [
            "50",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00079924.xml"
}